Bhutan vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Bhutan
100.0%
in 2024
Sur
82.0%
in 2024
Bhutan rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bhutan
- Sur
How they compare
Bhutan currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Bhutan's figure about 1.2 times Sur's.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was Bhutan ahead.
Bhutan ranks 1st and Sur ranks 2nd of 144 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 41.0% | 59.0% | Bhutan |
| 2010s | 92.9% | 70.3% | 22.6% | Bhutan |
| 2020s | 100.0% | 75.8% | 24.2% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bhutan or Sur?
- Bhutan, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bhutan and Sur?
- 18.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Sur?
- 14 years are reported by both, from 2008 to 2024.
- How do Bhutan and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bhutan ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.